Health Outcomes
Resource Center
Featured
04/07/2026
Anthony Calabro, MA
In a phase 3 randomized trial, investigators evaluated whether finerenone added to the background renin–angiotensin system blockade, thereby reducing albuminuria in adults with type 1 diabetes and chronic...
04/07/2026
03/12/2026
Anthony Calabro, MA
In a post-hoc analysis of ATTR-ACT, investigators examined whether baseline National Amyloidosis Center (NAC) stage influences long-term mortality, cardiovascular outcomes, and health status in patients...
03/12/2026
03/10/2026
In the phase 3 ACTG A5359 LATITUDE trial, investigators evaluated whether monthly, long-acting injectable cabotegravir plus rilpivirine could reduce regimen failure compared with standard oral...
03/10/2026
Interactive Features
11/13/2025
Anthony Calabro, MA
How do patients with chronic urticaria weigh efficacy, safety, and convenience when selecting therapy? This quiz, based on a JAMA Dermatology systematic review, explores patient values and preferences to...
11/13/2025
10/27/2025
Miranda Manier, BA
At the American Association of Nurse Practitioners 2025 National Conference, Sharon Bryant, DNP, MSN, ACNP-BC, explored how to differentiate cervical spine injury from routine musculoskeletal complaints in...
10/27/2025
10/07/2025
Anthony Calabro, MA
Explore our latest collection of must-read articles for primary care physicians—all in one place. This expertly curated page brings together timely, practical insights on combatting physician burnout to...
10/07/2025
09/25/2025
Miranda Manier, BA
In an interview with Consultant360, Junaid Anwar, MD, a hematology-oncology fellow at UT Health Houston, reviewed the current evidence base for JAK inhibitors in myelofibrosis from a pooled analysis of five...
09/25/2025
09/17/2025
Anthony Calabro, MA
How well do you understand the latest findings on fixed-duration acalabrutinib–venetoclax regimens in untreated chronic lymphocytic leukemia? Take this quiz to find out!
09/17/2025
Clinical Insights
02/27/2026
Norman Weinberg, MD
In this episode of Podcast360, Norman Weinberg, MD, a retired primary care internist with over 40 years of experience, discusses the intricacies of managing physician behavior and diagnostic errors.
02/27/2026
11/24/2025
Douglas DiRuggiero, DMSc, MHS, PA-C
Veteran dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares practical insights on how he incorporates ZORYVE® (roflumilast) into the treatment of atopic dermatitis, seborrheic...
11/24/2025
11/12/2025
Douglas DiRuggiero, DMSc, MHS, PA-C
In this episode of Ask the Experts, dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares what's unique about the formulations of ZORYVE® (roflumilast). Mr. DiRuggiero discusses how...
11/12/2025
11/04/2025
Daniel Lenihan, MD, FACC, FESC
Daniel Lenihan, MD, FACC, FESC, FIC-OS, a cardio-oncologist and founder of the International Cardio-Oncology Society, discusses cardiovascular risks associated with Bruton's tyrosine kinase inhibitors in...
11/04/2025
SOHO 2025 Conference Coverage
SOHO 2025 Conference Coverage
09/23/2025
Junaid Anwar, MD, discusses a meta-analysis of five landmark trials evaluating Janus kinase inhibitors for myelofibrosis, highlighting first-line efficacy and tolerability with ruxolitinib, second-line...
09/23/2025
